MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 12, 2019--
Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will
participate in the 8th Annual SVB Leerink Global Healthcare Conference
on Thursday, February 28, 2019 at the Lotte New York Palace in New York
City, and will present in a session at 9:30 a.m. ET.
A replay of the session will be available via the Investor Relations
section of the company’s website at www.intersectENT.com.
The webcast replay will be archived for approximately one month.
About Intersect ENT®
Intersect ENT is dedicated to transforming ear, nose and throat care by
providing innovative, clinically meaningful therapies to physicians and
patients. The company’s steroid releasing implants are designed to
provide mechanical spacing and deliver targeted therapy to the site of
disease. In addition, Intersect ENT is continuing to expand its
portfolio of products based on the company’s unique localized steroid
releasing technology and is committed to broadening patient access to
less invasive and more cost-effective care.
For additional information on the company or its products, including
risks and benefits, please visit www.IntersectENT.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190212005038/en/
Source: Intersect ENT, Inc.